DIFFERENTIAL CHEMOTHERAPEUTIC SUSCEPTIBILITY OF HUMAN T-LYMPHOCYTES AND B-LYMPHOCYTES IN CULTURE

被引：56

作者：

OHNUMA, T ^{[1
]}

ARKIN, H ^{[1
]}

MINOWADA, J ^{[1
]}

HOLLAND, JF ^{[1
]}

机构：

[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT IMMUNOL,BUFFALO,NY 14263

来源：

关键词：

D O I：

10.1093/jnci/60.4.749

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：749 / 752

页数：4

共 17 条

[1] BELPOMME D, 1977, LANCET, V1, P555
[2] BENTWICH Z, 1973, CLIN IMMUNOL IMMUNOP, V1, P511, DOI 10.1016/0090-1229(73)90007-X
[3] CAPIZZI RL, 1973, CANCER MED, P850
[4] IMMUNOSUPPRESSION BY L-ASPARAGINASE AND RELATED ENZYMES - REVIEW
HERSH, EM
[J]. TRANSPLANTATION, 1971, 12 (05) : 368 - &
[5] CYTOGENETIC STUDY OF HUMAN LYMPHOID T-CELL LINES DERIVED FROM LYMPHOCYTIC LEUKEMIA
HUANG, CC
HOU, Y
WOODS, LK
MOORE, GE
MINOWADA, J
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) : 655 - 660
[6] ROSETTE-FORMING HUMAN LYMPHOID-CELL LINE T-CELL LINE MOLT .2. ABILITY FOR CLONAL GROWTH
ITOH, U
MINOWADA, J
MOORE, GE
PRESSMAN, D
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (05) : 1403 - 1407
[7] LIVINGSTON RB, 1970, SINGLE AGENTS CANCER
[8] MINOWADA J, 1972, J NATL CANCER I, V49, P891
[9] MINOWADA J, 1967, CANCER, V20, P1430, DOI 10.1002/1097-0142(196709)20:9<1430::AID-CNCR2820200909>3.0.CO
[10] 2-H